Posted 28 March 2022
The Directorate of the Advertising Regulatory Board was called upon to consider a complaint against claims made on the Advertiser’s website https://www.optiway.co.za/ and heard during a radio commercial.
The Complainant submitted that there is insufficient evidence to show that this test, which is “… essentially an IgG type test ” can deliver on its claimed efficacy, that is, can detect foods which result in “food intolerance”.
The ARB concluded that in light of the adverse finding, the Advertiser is requested to withdraw this claim with immediate effect and within the deadlines stipulated in Clause 15.3 of the Procedural Guide.
Decision of the ADVERTISING REGULATORY BOARD
Complainant: Dr Harris Steinman
Advertiser: OptiWay
Consumer/Competitor: Consumer
File reference: 1926 – OptiWay Foods – Steinman
Outcome: Upheld
Date: 28 March 2022
The Directorate of the Advertising Regulatory Board has been called upon to consider a complaint against claims made on … Read the rest